English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/92581
Share/Impact:
Statistics
logo share SHARE   Add this article to your Mendeley library MendeleyBASE
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE
Exportar a otros formatos:

Title

Recombinant vectors based on the modified vaccinia anjara (MVA) virus, with deletion in the C6L gene, as vaccines against HIV/AIDS and other diseases

Other TitlesVectores recombinantes basados en el virus modificado de ankara (MVA), con deleción en el gen C6L, como vacunas contra el VIH/SIDA y otras enfermedades
AuthorsGarcía-Arriaza, Juan; Gómez, Carmen E.; Esteban, Mariano
Issue Date24-Jan-2013
CitationWO2013011179 A2
Abstract[EN] The invention falls within the fields of molecular biology and biotechnology. It specifically relates to recombinant viruses based on the modified vaccinia ankara (MVA) virus, that express the antigens gp120 and Gag-Pol-Nef of the human immunodeficiency virus (VIH-1) of sub-type B (MVA-B), and wherein the C6L vaccinia gene has been deleted, said recombinant viruses having been designed to be used as vaccines against HIV/AIDS and other diseases.
[ES] La presente invención engloba dentro de los campos de la biología molecular y de la biotecnología. Especificamente se refiere a virus recombinantes basados en el virus modificado de Ankara (MVA) que expresan los antigenos gp120 y Gag-Pol-Nef del virus de la inmunodeficienciahumana (VIH-1) de subtipo B (MVA-B), sobre los que see ha delecionado el gen de vaccinia C6L, y que han sido diseñados para utilizarse como vacunas contra el VIH/SIDA y otras enfermedades.
URIhttp://hdl.handle.net/10261/92581
Appears in Collections:(CNB) Patentes
Files in This Item:
File Description SizeFormat 
WO2013011179A2.pdf2,27 MBAdobe PDFThumbnail
View/Open
Show full item record
Review this work
 


WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.